Clonixin manufacturers
- Clonixin
-
- $1.00 / 1g
-
2021-01-06
- CAS:17737-65-4
- Min. Order: 1g
- Purity: 85.0-99.8%
- Supply Ability: 20ton
|
| | Clonixin Basic information |
| Product Name: | Clonixin | | Synonyms: | CLONIXIN;2-[(3-chloro-2-methylphenyl)amino]-3-pyridinecarboxylic acid;3-Pyridinecarboxylic acid, 2-[(3-chloro-2-methylphenyl)amino]-;CLONIXIC ACID (CLONIXIN);2-(3-CHLORO-2-METHYLPHENYLAMINO)NICOTINIC ACID;2-(3-Chloro-2-methylanilino)pyridine-3-carboxylic acid;2-(3-Chloro-o-toluidino)nicotinic acid;Sch-10304 | | CAS: | 17737-65-4 | | MF: | C13H11ClN2O2 | | MW: | 262.69 | | EINECS: | 241-730-1 | | Product Categories: | Organics | | Mol File: | 17737-65-4.mol |  |
| | Clonixin Chemical Properties |
| Melting point | 233-235° | | Boiling point | 410.2±45.0 °C(Predicted) | | density | 1.3230 (rough estimate) | | refractive index | 1.5270 (estimate) | | storage temp. | Keep in dark place,Inert atmosphere,Room temperature | | solubility | DMSO: soluble15mg/mL, clear | | form | powder | | pka | 1.69±0.36(Predicted) | | color | white to beige | | Merck | 14,2392 | | CAS DataBase Reference | 17737-65-4(CAS DataBase Reference) |
| Hazard Codes | Xn | | Risk Statements | 20/21/22 | | Safety Statements | 36/37 | | WGK Germany | 3 | | RTECS | QT0960000 | | HS Code | 2933.39.9200 | | Toxicity | LD50 in male mice, rats (mg/kg): 415, 335 orally; 198, 148 i.p.; 296, 325 s.c. (Tanaka) |
| | Clonixin Usage And Synthesis |
| Uses | Analgesic. | | Uses | Clonixin is a non-steroidal anti-inflammatory drug. It also has analgesic, antipyretic, and platelet-inhibitory actions. The compound has been reported to block prostaglandin synthesis, and to block inward calcium currents. | | Definition | ChEBI: A pyridinemonocarboxylic acid that is nicotinic acid substituted at position 2 by a (2-methyl-3-chlorophenyl)amino group. Used (as its lysine salt) for treatment of renal colic, muscular pain and moderately severe migraine attacks. |
| | Clonixin Preparation Products And Raw materials |
|